These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 6455096)

  • 1. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
    Groggins RC; Milner AD; Stokes GM
    Arch Dis Child; 1981 May; 56(5):342-4. PubMed ID: 6455096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulised ipratropium bromide in wheezy infants and young children.
    Stokes GM; Milner AD; Hodges IG; Henry RL
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():494-8. PubMed ID: 6225670
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of ketotifen with clemastine, ipratropium bromide and sodium cromoglycate in exercise-induced asthma.
    Dorward AJ; Patel KR
    Clin Allergy; 1982 Jul; 12(4):355-61. PubMed ID: 6214337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipratropium bromide in acute asthma.
    Ward MJ; Fentem PH; Smith WH; Davies D
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):598-600. PubMed ID: 6451257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
    Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
    Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.
    Sly PD; Landau LI; Olinsky A
    Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator effect of two inhaled H1-receptor antagonists, clemastine and chlorpheniramine, in wheezy school-children.
    Hodges IG; Milner AD; Stokes GM
    Br J Dis Chest; 1983 Jul; 77(3):270-5. PubMed ID: 6351890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma.
    Leahy BC; Gomm SA; Allen SC
    Br J Dis Chest; 1983 Apr; 77(2):159-63. PubMed ID: 6223651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ; Trieu L; Van Asperen P
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilatation after inhalation of the antihistamine clemastine.
    Nogrady SG; Hartley JP; Handslip PD; Hurst NP
    Thorax; 1978 Aug; 33(4):479-82. PubMed ID: 694800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipratropium bromide in patients with nocturnal asthma.
    Cox ID; Hughes DT; McDonnell KA
    Postgrad Med J; 1984 Aug; 60(706):526-8. PubMed ID: 6236436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salbutamol and ipratropium in acute asthma.
    Rayner RJ; Cartlidge PH; Upton CJ
    Arch Dis Child; 1987 Aug; 62(8):840-1. PubMed ID: 2959208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulised ipratropium and salbutamol in asthma.
    Storr J; Lenney W
    Arch Dis Child; 1986 Jun; 61(6):602-3. PubMed ID: 2942116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of a combination of bronchodilators.
    Casali L; Grassi C; Rampulla C; Rossi A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):277-80. PubMed ID: 157338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma.
    Hossain AS; Barua UK; Roy GC; Sutradhar SR; Rahman I; Rahman G
    Mymensingh Med J; 2013 Apr; 22(2):345-52. PubMed ID: 23715360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator responses to nebulised ipratropium and salbutamol singly and in combination in chronic bronchitis.
    Chan CS; Brown IG; Kelly CA; Dent AG; Zimmerman PV
    Br J Clin Pharmacol; 1984 Jan; 17(1):103-5. PubMed ID: 6229262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients.
    Fontana G; Mugnai M; Cresci F; Panuccio P
    Respiration; 1986; 50 Suppl 2():201-5. PubMed ID: 2951806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma.
    Memon BN; Parkash A; Ahmed Khan KM; Gowa MA; Bai C
    J Pak Med Assoc; 2016 Mar; 66(3):243-6. PubMed ID: 26968269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients.
    Bell R; Sahay JN; Barber PV; Chatterjee SS; Cox G
    Curr Med Res Opin; 1982; 8(4):242-6. PubMed ID: 6217949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.